Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice.

[1]  D. Kastner,et al.  Autoinflammatory Disease Reloaded: A Clinical Perspective , 2010, Cell.

[2]  S. Ozen,et al.  Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease , 2010, Clinical Rheumatology.

[3]  D. Kastner,et al.  Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy , 2009, British journal of haematology.

[4]  D. Kastner,et al.  Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. , 2009, Immunity.

[5]  M. Pras,et al.  Clinical disease among patients heterozygous for familial Mediterranean fever. , 2009, Arthritis and rheumatism.

[6]  S. Holland,et al.  Familial Mediterranean fever with a single MEFV mutation: where is the second hit? , 2009, Arthritis and rheumatism.

[7]  S. Ozen.  Changing concepts in familial Mediterranean fever: is it possible to have an autosomal-recessive disease with only one mutation? , 2009, Arthritis and rheumatism.

[8]  Seth L Masters,et al.  Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). , 2009, Annual review of immunology.

[9]  G. Pohl,et al.  Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  D. Kastner,et al.  The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. , 2008, Blood.

[11]  R. Roldán,et al.  Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine. , 2008, Joint, bone, spine : revue du rhumatisme.

[12]  V. Nizet,et al.  A Nod2–nalp1 Complex Mediates Caspase-1-dependent Il-1␤ Secretion in Response to Bacillus Anthracis Infection and Muramyl Dipeptide Nod2, a Nod-like Receptor (nlr), Is an Intracellular Sensor of Bacterial Muramyl Dipeptide (mdp) That Was Suggested to Promote Secretion of the Proinflammatory Cytokine , 2022 .

[13]  E. Alnemri,et al.  Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. , 2007, Molecular cell.

[14]  J. Frenkel,et al.  Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra , 2007, Annals of the rheumatic diseases.

[15]  A. Ventura,et al.  The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever , 2007, European Journal of Pediatrics.

[16]  E. Hachulla,et al.  Treatment of familial Mediterranean fever with anakinra. , 2007, Annals of internal medicine.

[17]  F. Martinon,et al.  The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1β processing , 2007, Cell Death and Differentiation.

[18]  Brian J. Smith,et al.  The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Booth,et al.  Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. , 2006, Rheumatology.

[20]  V. Dixit,et al.  Cryopyrin activates the inflammasome in response to toxins and ATP , 2006, Nature.

[21]  J. Bertin,et al.  Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. , 2006, Immunity.

[22]  E. Alnemri,et al.  Cryopyrin and pyrin activate caspase-1, but not NF-κB, via ASC oligomerization , 2006, Cell Death and Differentiation.

[23]  D. Kastner,et al.  Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts in human synovial fibroblasts: a prominent splice isoform lacks the C-terminal domain that is highly mutated in familial Mediterranean fever. , 2004, Arthritis and rheumatism.

[24]  J. Hugot,et al.  Infevers: An evolving mutation database for auto‐inflammatory syndromes , 2004, Human mutation.

[25]  D. Kastner,et al.  Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. , 2003, Molecular cell.

[26]  T. Roscioli,et al.  Allogeneic bone marrow transplantation: cure for familial Mediterranean fever. , 2002, Blood.

[27]  P. Tucker,et al.  Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states , 2001, Nature Genetics.

[28]  D. Kastner,et al.  TNFRSF1A mutations and autoinflammatory syndromes. , 2000, Current opinion in immunology.

[29]  A. Dutra,et al.  Isolation, genomic organization, and expression analysis of the mouse and rat homologs of MEFV, the gene for familial Mediterranean fever , 2000, Mammalian Genome.

[30]  S. Holland,et al.  The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. , 2000, Blood.

[31]  Jacques Demaille,et al.  A candidate gene for familial Mediterranean fever , 1997, Nature Genetics.

[32]  F. Collins,et al.  Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever , 1997, Cell.

[33]  E. Sohar,et al.  Familial Mediterranean fever. , 1955, Klinische Padiatrie.

[34]  E. Sohar,et al.  FAMILIAL MEDITERRANEAN FEVER , 1959, Definitions.